KR840003028A - 종양치료제의 오일상 조성물의 제조방법 - Google Patents

종양치료제의 오일상 조성물의 제조방법 Download PDF

Info

Publication number
KR840003028A
KR840003028A KR1019830000188A KR830000188A KR840003028A KR 840003028 A KR840003028 A KR 840003028A KR 1019830000188 A KR1019830000188 A KR 1019830000188A KR 830000188 A KR830000188 A KR 830000188A KR 840003028 A KR840003028 A KR 840003028A
Authority
KR
South Korea
Prior art keywords
tumor therapeutic
oily composition
preparing
preparing oily
oily
Prior art date
Application number
KR1019830000188A
Other languages
English (en)
Other versions
KR900005044B1 (ko
Inventor
히로이쯔 가와따 (외 7)
Original Assignee
모리오까 시게오
야마노우찌 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP799782A external-priority patent/JPS58124714A/ja
Application filed by 모리오까 시게오, 야마노우찌 세이야꾸 가부시끼 가이샤 filed Critical 모리오까 시게오
Publication of KR840003028A publication Critical patent/KR840003028A/ko
Application granted granted Critical
Publication of KR900005044B1 publication Critical patent/KR900005044B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

종양치료제의 오일상 조성물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 수용성 또는 오일에 거의 녹지 않는 종양치료제 하나 이상과 크라운 에테르, 레시틴, 폴리에틸렌글리콜, 프로필렌글리콜, 비타민 E, 폴리옥시에틸렌 알킬에테르 및 지방산의 슈크로즈 에스테르 중에서 선택된, 오일상 베히클 중의 가용화 보조제 하나 이상을 지방 및 오일 하나 이상에 용해 또는 유화시킴을 특징으로 하여 종양치료제의 오일상 조성물을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830000188A 1982-01-20 1983-01-19 종양치료제의 오일상 조성물의 제조방법 KR900005044B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP57-7997 1982-01-20
JP799782A JPS58124714A (ja) 1982-01-20 1982-01-20 抗腫瘍物質の油性組成物
JP7997 1982-01-20
JP21504982 1982-12-08
JP215049 1987-08-31

Publications (2)

Publication Number Publication Date
KR840003028A true KR840003028A (ko) 1984-08-13
KR900005044B1 KR900005044B1 (ko) 1990-07-18

Family

ID=26342413

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000188A KR900005044B1 (ko) 1982-01-20 1983-01-19 종양치료제의 오일상 조성물의 제조방법

Country Status (6)

Country Link
US (1) US4578391A (ko)
KR (1) KR900005044B1 (ko)
DE (1) DE3301638A1 (ko)
FR (1) FR2519864B1 (ko)
GB (1) GB2114885B (ko)
IT (1) IT1193128B (ko)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028916A (ja) * 1983-07-13 1985-02-14 Yamanouchi Pharmaceut Co Ltd アクラルビシンまたはその塩酸塩の油性組成物
HU197212B (en) * 1985-08-02 1989-03-28 Merz & Co Gmbh & Co Process for producing pharmaceuticals with antiviral and antitumour effect
US5389366A (en) * 1986-09-19 1995-02-14 Yamanouchi Pharmaceutical Co., Ltd. Neocarzinostatin derivative composition for oral administration
JP2556865B2 (ja) * 1986-09-19 1996-11-27 山之内製薬株式会社 ネオカルチノスタチン誘導体の非注射投与用組成物
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
JPH0794377B2 (ja) * 1987-07-22 1995-10-11 呉羽化学工業株式会社 エストラジオール誘導体を含有する注射剤
US5216011A (en) * 1989-09-01 1993-06-01 Bristol-Myers Squibb Co. Stable solutions of mitomycin c
US5496533A (en) * 1992-07-31 1996-03-05 Australian Nuclear Science & Technology Organisation Rhenium complexes
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
GB9424901D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Sequestration Agents
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
GB9618420D0 (en) 1996-09-04 1996-10-16 Scotia Holdings Plc Fatty acid treatment
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6117852A (en) * 1997-12-29 2000-09-12 National Science Council Boron-containing lipiodol for boron neutron capture therapy of hepatoma
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
AU755443C (en) * 1998-07-20 2006-08-17 Virbac (Australia) Pty Limited Bioimplant formulation
MXPA01000674A (es) 1998-07-20 2002-04-08 Peptech Ltd Formulacion de bioimplante.
US6463256B2 (en) * 1999-03-31 2002-10-08 Hewlett-Packard Company Duplexing module for printer
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US6420358B1 (en) 1999-09-27 2002-07-16 American Cyanamid Company Vasopressin antagonist and diuretic combination
US6352718B1 (en) 1999-09-27 2002-03-05 American Cyanamid Company Vasopressin antagonist formulation and process
US6831079B1 (en) 1999-09-27 2004-12-14 American Cyanamid Company Vasopressin agonist formulation and process
AU2001225432A1 (en) * 2000-01-20 2001-07-31 Supratek Pharma, Inc. Novel podophyllotoxin compositions
AUPR644301A0 (en) * 2001-07-17 2001-08-09 Unisearch Limited Method and composition for treatment of cancer
US7094771B2 (en) * 2002-07-15 2006-08-22 National Tsing Hua University Pharmaceutical composition for boron neutron capture therapy containing triphenylboroxin
JP2006056781A (ja) * 2002-11-15 2006-03-02 Bioserentack Co Ltd 界面活性剤を含む固形化製剤
EP1592760A4 (en) * 2003-01-31 2009-08-12 Smithkline Beecham Corp AS FIXED DISPERSIONS, COMPOSITIONS
US20070167422A1 (en) * 2006-01-18 2007-07-19 Yu Kwok S Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
CN102260216A (zh) * 2010-05-28 2011-11-30 李茂全 5-氟尿嘧啶亲脂性衍生物碘化油
CN111298189A (zh) * 2018-12-11 2020-06-19 陈传果 一种易于推注的碘化油栓塞剂及其制备方法
CN109821055A (zh) * 2019-02-01 2019-05-31 厦门大学 一种药物-碘油溶剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5393M (ko) * 1964-09-22 1967-10-30
US4104461A (en) * 1973-04-16 1978-08-01 Research Corporation 2,2'-Anhydro-β-D-arabinofuranosyl-5-fluorocytosine
US4011661A (en) * 1973-10-30 1977-03-15 Kyowa Hakko Kogyo Co., Ltd. Powdered emulsion product and method of production
JPS5439098A (en) * 1977-08-31 1979-03-24 Kyowa Hakko Kogyo Co Ltd Mitomycin c derivatives
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
JPS5686114A (en) * 1979-12-17 1981-07-13 Medeiseru Kenkyusho:Kk Pharmaceutical composition for suppository

Also Published As

Publication number Publication date
KR900005044B1 (ko) 1990-07-18
GB2114885A (en) 1983-09-01
IT8367055A0 (it) 1983-01-19
IT1193128B (it) 1988-06-02
FR2519864B1 (fr) 1985-09-27
US4578391A (en) 1986-03-25
DE3301638A1 (de) 1983-08-04
GB2114885B (en) 1985-09-04
GB8301566D0 (en) 1983-02-23
DE3301638C2 (ko) 1989-08-24
FR2519864A1 (fr) 1983-07-22

Similar Documents

Publication Publication Date Title
KR840003028A (ko) 종양치료제의 오일상 조성물의 제조방법
KR900013063A (ko) 유지류의 산화억제 방법
ATE118177T1 (de) Emulsion.
ATE141780T1 (de) Öl in wasser emulsionen verwendbar für die herstellung von einer creme
DK0759773T3 (da) Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv
MX9304777A (es) Composiciones para el cuidado de la piel que contienen imidazoles.
JPS5729213B2 (ko)
DE3681286D1 (de) Behandlung von emulsionen.
ES458280A1 (es) Un procedimiento para la preparacion de una emulsion de a- ceite en agua.
DE3381777D1 (de) Einfach absorbierbare fettsaeureemulsionen.
ES2102513T3 (es) Procedimiento para separar una impureza de ester de un eter.
ATE164880T1 (de) Fettenschleimungsverfahren und so erhaltenes fett
ES444983A1 (es) Procedimiento de preparacion de emulsiones estables de agua en aceite.
ATE210953T1 (de) Kosmetische pit-emulsionen
ES2085991T3 (es) Esteres y fluidos que los contienen.
ATE146699T1 (de) Eine emulsion von öl in wasser
JPS5269909A (en) Water-in-oil emulsion fuel
JPS5511526A (en) Cosmetic
KR950010876A (ko) 피부외용제
MXPA01011815A (es) Utilizacion dce emulsiones pit en procesos de fermentacion.
SE7701174L (sv) Solskyddsolja
ES8402160A1 (es) Un metodo para producir una composicion oleosa de un farmaco antitumoral.
JPS52124007A (en) Continuous fractionation of edible fats and oils without using solvents
SE8001236L (sv) Forfarande for framstellning av kasein med lag kolesterolhalt
JPS5241915A (en) Compressor

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19950710

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee